pointbiopharma(PNT) - 2021 Q4 - Annual Report

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Washington, D.C. 20549 FORM 10-K Commission File Number 001-39311 POINT BIOPHARMA GLOBAL INC. (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 4850 West 78th Street, Indianapolis, IN 46268 (647) 812-2417 (Address, including zip ...